T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver shield: nutrient may prevent chemo side effect in young leukemia patients
Disease control OngoingThis study tests whether adding levocarnitine, a natural nutrient, to standard chemotherapy can prevent severe liver damage in teens and young adults (ages 15-39) with leukemia or lymphoma. Liver toxicity from the chemotherapy drug asparaginase often forces treatment delays, whic…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 17, 2026 03:28 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control OngoingThis study tests whether two drugs, venetoclax and azacitidine, can help prevent leukemia from returning in 100 adults who have already had a stem cell transplant. Participants must be between 18 and 75 years old and in remission after transplant. The goal is to see if this combi…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New combo therapy aims to tame tough leukemia with fewer side effects
Disease control OngoingThis study looks at children and teens with a specific type of leukemia called Philadelphia chromosome-positive ALL. It tests whether a targeted drug called imatinib works as well with a milder chemotherapy regimen as it does with a stronger one, but with fewer side effects. The …
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 07, 2026 18:43 UTC